Stay updated on Faricimab in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays site revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-17T17:16:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record for the TENAYA faricimab trial is displayed, including its design, eligibility criteria, locations, outcome measures, results-related publications, and study documents.
    Difference
    100%
    Check dated 2026-11-10T16:37:41.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T16:52:09.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label advances from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T18:51:54.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:31:22.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    403 Forbidden page now replaces the study record, turning the page into an access-denied screen. The study details, documents, and related content are no longer visible to users.
    Difference
    18%
    Check dated 2026-09-22T21:54:18.000Z thumbnail image

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.